Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
International Journal of Molecular Sciences
|
July 24, 2021
Recent Advances in Kinase Drug Discovery Part I: The Editors' Take
Julie A Tucker, Mathew P Martin
Acta Crystallographica. Section D, Structural Biology
|
November 2, 2022
Exiting the tunnel of uncertainty: crystal soak to validated hit
Mathew P Martin, Martin E M Noble
Essays in Biochemistry
|
November 10, 2017
Structure-based discovery of cyclin-dependent protein kinase inhibitors
Mathew P Martin, Jane A Endicott, Martin E M Noble
Chemmedchem
|
May 3, 2016
Discovery of Diverse Small-Molecule Inhibitors of Mammalian Sterile20-like Kinase 3 (MST3)
Sanne H Olesen, Jin-Yi Zhu, Mathew P Martin, et al.
ACS Chemical Biology
|
September 7, 2013
Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains
Mathew P Martin, Sanne H Olesen, Gunda I Georg, et al.
Current Opinion in Structural Biology
|
January 19, 2025
Different applications and differentiated libraries for crystallographic fragment screening
Jessica Watt, Mathew P Martin, Jane A Endicott, et al.
Methods in Enzymology
|
October 20, 2023
Crystallographic fragment screening in academic cancer drug discovery
Mathew P Martin, Jane A Endicott, Martin E M Noble, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 16, 2012
A novel approach to the discovery of small-molecule ligands of CDK2
Mathew P Martin, Riazul Alam, Stephane Betzi, et al.
Journal of Medicinal Chemistry
|
April 1, 2023
Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy
Duncan C Miller, Suzannah J Harnor, Mathew P Martin, et al.
Structure (London, England : 1993)
|
August 15, 2025
Crystallographic fragment screening of CDK2-cyclin A: FragLites map sites of protein-protein interaction
Ian Hope, Mathew P Martin, Ziwei Jiang, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
International Journal of Molecular Sciences
|
July 24, 2021
Recent Advances in Kinase Drug Discovery Part I: The Editors' Take
Julie A Tucker, Mathew P Martin
Acta Crystallographica. Section D, Structural Biology
|
November 2, 2022
Exiting the tunnel of uncertainty: crystal soak to validated hit
Mathew P Martin, Martin E M Noble
Essays in Biochemistry
|
November 10, 2017
Structure-based discovery of cyclin-dependent protein kinase inhibitors
Mathew P Martin, Jane A Endicott, Martin E M Noble
Chemmedchem
|
May 3, 2016
Discovery of Diverse Small-Molecule Inhibitors of Mammalian Sterile20-like Kinase 3 (MST3)
Sanne H Olesen, Jin-Yi Zhu, Mathew P Martin, et al.
ACS Chemical Biology
|
September 7, 2013
Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains
Mathew P Martin, Sanne H Olesen, Gunda I Georg, et al.
Current Opinion in Structural Biology
|
January 19, 2025
Different applications and differentiated libraries for crystallographic fragment screening
Jessica Watt, Mathew P Martin, Jane A Endicott, et al.
Methods in Enzymology
|
October 20, 2023
Crystallographic fragment screening in academic cancer drug discovery
Mathew P Martin, Jane A Endicott, Martin E M Noble, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 16, 2012
A novel approach to the discovery of small-molecule ligands of CDK2
Mathew P Martin, Riazul Alam, Stephane Betzi, et al.
Journal of Medicinal Chemistry
|
April 1, 2023
Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy
Duncan C Miller, Suzannah J Harnor, Mathew P Martin, et al.
Structure (London, England : 1993)
|
August 15, 2025
Crystallographic fragment screening of CDK2-cyclin A: FragLites map sites of protein-protein interaction
Ian Hope, Mathew P Martin, Ziwei Jiang, et al.
Page
of 4